PTC Therapeutics, Inc.
PTCT· Nasdaq
Released Nov 2, 2017, after the close
10-Q filed Nov 2, 2017, 33 days after period end · 0001070081-17-000128
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $41.78M | $22.99M | $9.78M | $1.69M |
| Net Income | -$33.74M | -$35.17M | -$43.22M | -$27.28M |
| EPS Diluted | -$0.82 |
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR
| -$1.03 |
| -$1.27 |
| -$0.93 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.